On March 27, 2024, Ayala Pharmaceuticals, Inc. and Roy Golan, Chief Financial Officer, agreed that Mr. Golan would depart the Company on June 25, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.665 USD | +19.82% | +16.26% | -0.30% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.30% | 23.66M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Ayala Pharmaceuticals, Inc. Announces Departure of Roy Golan as Chief Financial Officer, Effective from June 25, 2024